ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GDR Genedrive Plc

1.65
0.025 (1.54%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.025 1.54% 1.65 1.60 1.70 1.70 1.625 1.63 27,752,936 15:13:46
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -1.74 8.96M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.63p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 17.50p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £8.96 million. Genedrive has a price to earnings ratio (PE ratio) of -1.74.

Genedrive Share Discussion Threads

Showing 5276 to 5294 of 27075 messages
Chat Pages: Latest  219  218  217  216  215  214  213  212  211  210  209  208  Older
DateSubjectAuthorDiscuss
28/1/2021
13:27
BUYERS PUSHING share price back up more already

not even 2pm yet ,how strong an afternoon looks to be ahead with this buying already
will 90 p be passed or a £1 be passed this afternoon

bunz3
28/1/2021
13:13
SOME Chunky buys
bunz3
28/1/2021
13:00
Well, we already have lift off!🔥㉀0;🚀🚀🚀

To the moon it is then!!!!!📈

uk2day
28/1/2021
12:55
Can you imagine if they reveal contract revenue on the scale of NCYT for the next 6 months......with the number of shares in circulation and market cap, the price will be more than moonshot....another bloody galaxy!!!
k1ngkonggb
28/1/2021
12:51
How many shorters were toast after todays RNS?😂㈳4;😂
uk2day
28/1/2021
12:48
how many building up holdings for February after Todays rns
bunz3
28/1/2021
12:41
BC to release statement at 1:30 GMT
hooded claw
28/1/2021
12:38
Good luck to you guysIve taken my 22k profit after a long wait... and it was a long wait
phurley
28/1/2021
12:36
was some one silly enough to short a share like gdr with so much good news due ,

as has been Today again


Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing

bunz3
28/1/2021
12:34
When USA awakens rthen be interesting to see how this moves with Todays rns

and
Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing

bunz3
28/1/2021
12:33
justtrying1 - 28 Jan 2021 - 11:10:25 - 3396 of 3419
Price dropping now

Lol you posted this at 73p!😂㈳4;😂

Fool!!!!

uk2day
28/1/2021
12:30
so strong of buying

when USA Markets poen how interesting might be to watch then

bunz3
28/1/2021
12:25
25 ,000 share buy
bunz3
28/1/2021
12:24
When USA awakens rthen be interesting to see how this moves with Todays rns

and
Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing

bunz3
28/1/2021
12:18
The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.
bunz3
28/1/2021
12:17
David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

bunz3
28/1/2021
12:15
when USA market opens ,Will interest be seen from USA around 2pm 0r 3pm
bunz3
28/1/2021
12:13
The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.
bunz3
28/1/2021
12:12
David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

bunz3
Chat Pages: Latest  219  218  217  216  215  214  213  212  211  210  209  208  Older